Space Lintech
Space LiinTech is a South Korean space-based biopharma company that provides microgravity protein crystallization, bioprocess, and gene-delivery research services to pharmaceutical and biotechnology firms, using its proprietary BEE platform modules on the ISS, LEO satellites, and ground-based drop towers.
- Company typePrivate
- Founded2021
- HeadquartersDaejeon, South Korea
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Space Lintech does
Space LiinTech is a South Korean space-based biopharma company founded in June 2021 and headquartered in Daejeon that provides microgravity research and manufacturing services to pharmaceutical and biotechnology firms. Its core offering is the BEE (Biomedical Extraterrestrial Enclosure) platform family — standardized and customizable experiment modules compatible with the ISS EXPRESS Rack — anchored by BEE-PC1 (Korea's first protein crystallization module on the ISS, demonstrated August 2025), BEE-1000 (the world's first protein pharmaceutical crystallization module in LEO, launched November 2025 on Nuri Flight 4), and BEE-1012 (scheduled for Nuri Flight 5). These space-based assets are vertically integrated with ground-based microgravity simulation infrastructure including the 600m Jeongseon Drop Tower (co-developed with the Institute for Basic Science), a 900m Taebaek Drop Tower under construction, and the Giheung Gravity Lab for iterative protocol validation. The company also markets Gravito-Electroporation, a proprietary gene-delivery platform for cell therapies combining electroporation with controlled gravity conditions.
Space LiinTech monetizes its platform through four contract-based revenue streams: (1) protein crystallization contract research services addressing Earth-based limitations including convection, secondary nucleation, aggregation, and polymorphism; (2) emerging contract manufacturing for pharmaceuticals and APIs in microgravity using BEE-FRM/FPM modules; (3) ground-based drop tower validation services for transfection research and protocol development; and (4) end-to-end ISS and satellite payload integration, mission operations, and data delivery services. Pricing is determined on a project-by-project basis following detailed scoping of experiment requirements. Target customer segments are large pharmaceutical companies and biotechnology firms (both primary), with CRO/CDMOs as a secondary channel.
The company serves its customers through direct enterprise field sales supplemented by a heavy industry-conference presence (CES 2026, IAC 2025, BIO KOREA 2025) and government engagement, including selection for the Korean ARPA-H Project (December 2024) and Deep Tech TIPS program (June 2023). It has built a strategic partnership network spanning Voyager Technologies (ISS payload integration), Mobilint (AI compute), Innospace and Intergravity (LEO manufacturing platform), Perigee Aerospace (suborbital launches), and Massachusetts General Hospital (BBB drug delivery research), with a global office opened in Boston in December 2025 to support international business development.
Space Lintech firmographics
Firmographics- Name
- Space Lintech
- Legal name
- SPACELIINTECH
- Website
- https://spaceliintech.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Space LiinTech is a South Korean space-based biopharma company that provides microgravity protein crystallization, bioprocess, and gene-delivery research services to pharmaceutical and biotechnology firms, using its proprietary BEE platform modules on the ISS, LEO satellites, and ground-based drop towers.
- Ownership category
- akta.pro rank
Space Lintech industry classification
Industry- Product category
- Space-based Biopharmaceutical Research Services
- NAICS
- Search, Detection, Navigation, Guidance, Aeronautical, and Nautical System and Instrument Manufacturing (334511), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Guided Missiles & Space Vehicles & Parts (3760), Laboratory Analytical Instruments (3826), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Space Payloads & Instruments (Sensors, Comms, EO/IR) (IMABACAD)
- akta.pro secondary industries
- Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF), General Lab Equipment (Centrifuges, Incubators, Shakers, Ovens) (HLAGAIAC), Space Logistics & In-Orbit Servicing (Refueling, Tug, Debris Removal) (IMABACAM)
Keywords
Where Space Lintech is headquartered
LocationHeadquarters
- HQ city
- Daejeon
- HQ country
- South Korea
- HQ region
- Asia
Offices4 records
Markets served
Space Lintech business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales
Revenue model
- Contract Research Services - Protein Crystallization: Space LiinTech provides contract research services for protein crystallization under microgravity conditions on the ISS and LEO satellites. This addresses gravity-related limitations observed on Earth including convection, secondary nucleation, aggregation, and polymorphism. The service supports structure-based drug discovery workflows for pharmaceutical and biotech clients.
- Contract Manufacturing - Pharmaceuticals and APIs: Developing microgravity-enabled production modules and contract-based manufacturing capabilities for pharmaceuticals and active pharmaceutical ingredients (APIs). This supports Korea's growing API ecosystem by exploring scalable production approaches in space with automation, real-time environmental monitoring, and advanced process control.
- Technology Development and Validation Services: Provides ground-based drop tower experiments and validation services for transfection research and protocol validation. Supports development and validation of space biopharmaceutical technologies including gene delivery workflows for cell and gene therapies.
- ISS and Satellite Payload Services: End-to-end mission support covering payload integration, safety and ISS compatibility processes, mission operations, data delivery, and post-mission analysis for biopharma research in space.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels5 records
Space Lintech product offering
Product offeringCore offering
Space Lintech provides microgravity-enabled contract research services and biopharma platforms for the pharmaceutical and biotechnology industries. Its core products are the BEE (Biomedical Extraterrestrial Enclosure) platform family—including BEE-PC1, BEE-1000, BEE-1012, and BEE-FRM/FPM—that enable protein crystallization, bioprocess studies, and API manufacturing on the ISS and in LEO satellites. Complementing the space hardware are ground-based drop towers, the Gravito-Electroporation gene delivery platform for cell therapies, and end-to-end payload integration and mission operations services.
Product overview
Space LiinTech is a space-based biopharma platform company offering an integrated portfolio of microgravity experiment systems and contract research services. The core offering centers on the BEE (Biomedical Extraterrestrial Enclosure) platform family—including BEE-PC1 for ISS-based protein crystallization, BEE-1000 and BEE-1012 for LEO satellite-based research, and BEE-FRM/FPM for in-orbit manufacturing—all compatible with ISS EXPRESS Rack. The company complements space-based operations with ground-based drop tower facilities (Jeongseon 600m, Taebaek 900m, and Giheung Gravity Lab) for iterative testing and protocol validation. The Gravito-Electroporation platform provides proprietary gene delivery technology for cell therapies. Services include contract research for protein crystallization and API manufacturing in microgravity. The company connects ground validation through drop towers with in-orbit research via ISS modules and LEO satellite platforms.
Differentiator
Problem solved
Functional benefit
Brands
- BEE Platform: Biomedical Extraterrestrial Enclosure platform for ISS-based biopharma research, including BEE-PC1 for protein crystallization and BEE-1000 for satellite-based research.
- BEE-PC1
- BEE-1000
- Gravito-Electroporation
Products and services
- BEE-PC1 (Biomedical Extraterrestrial Enclosure - Protein Crystallization) ISS-based autonomous protein crystallization module compatible with the ISS EXPRESS Rack, executing experiments autonomously with minimal astronaut involvement and featuring real-time monitoring through onboard sensors and internal imaging. Intended for pharmaceutical and biotech clients performing structure-based drug discovery.
- BEE-1000 (Biomedical Extraterrestrial Enclosure LEO Satellite Platform) LEO satellite-based microgravity biopharma research platform enabling protein crystallization and in-orbit validation. Designed to support scalable biopharma R&D and to provide an alternative to ISS-based experimentation for pharmaceutical and biotech clients.
- Gravito-Electroporation Platform Proprietary gene delivery technology for cell therapies that combines electroporation with controlled gravity conditions to deliver genetic material across diverse cell types while minimizing cell stress and damage. Used by biotech clients developing cell and gene therapies.
- Space Biopharma Contract Research Services End-to-end contract research services for protein crystallization under microgravity conditions on the ISS and LEO satellites, addressing gravity-related limitations to enable growth of larger and more uniform crystals for high-resolution structural analysis and structure-based drug discovery. Targeted at pharmaceutical and biotech clients.
- Microgravity API Manufacturing Services Contract-based manufacturing services for pharmaceuticals and active pharmaceutical ingredients (APIs) using microgravity, supporting scalable production approaches in space with automation, real-time environmental monitoring, and advanced process control. Designed for pharmaceutical and biotech manufacturers seeking high-purity biologics and APIs that are challenging to stabilize under Earth gravity.
Quantifiable outcome
- Korea's first protein crystallization module on the ISS demonstrated successfully in August 2025
- +3 more outcomes
Companies that use Space Lintech
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
Space Lintech technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature7 records
Space Lintech partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core, flagship and minor.
- MobilintcoreStrategic business agreement with AI semiconductor company Mobilint to jointly develop an AI space payload utilizing Mobilint's Neural Processing Unit (NPU) technology, optimized for the space environment. The partnership aims to address technical requirements for AI computations under power, heat, and communication constraints while expanding Space LiinTech's space medicine research platform capabilities.
- Voyager TechnologiescoreNew contract with Voyager Technologies to send research payloads to the International Space Station for microgravity drug discovery. The collaboration focuses on evaluating microgravity's effects on protein crystallization to improve drug formulations and involves testing an AI-driven automation system. Voyager Technologies' stock rose 2.9% following the announcement.
- Innospace and IntergravityflagshipMOU signing for commercializing a Low-Earth Orbit Space Medicine Manufacturing Platform. Three-way agreement between Space LiinTech, Innospace (launch vehicle provider), and Intergravity to establish space-based pharmaceutical manufacturing capabilities.
- STEPLabminorMOU signed with STEPLab for collaboration on space medicine technology development and research initiatives.
- Voyager TechnologiescoreMOU signed with Voyager Technologies for collaboration on space medicine research and commercial space station initiatives. Voyager Technologies is building starlab, a next-generation commercial space station.
- Handuk Iron MineminorMOU signed for microgravity experiment facility operation, utilizing the Handuk Iron Mine vertical shaft for drop tower operations.
- Perigee AerospacecoreMOU signed to strengthen collaboration with Perigee Aerospace for low-Earth orbit platform research. Space LiinTech signed contract with Perigee Aerospace in November 2023 for suborbital launch vehicle BEE-1000 payload integration.
- Institute for Basic Science (IBS)coreMOU with IBS for collaboration on microgravity research. Space LiinTech established Jeongseon Research Center within IBS Yemi Lab in March 2024. The IBS Jeongseon Drop Tower was developed in collaboration with IBS.
- Jeongseon CountyminorMOU signed with Jeongseon County for space medicine research collaboration and drop tower facility support.
- Massachusetts General HospitalcoreJoint research with Massachusetts General Hospital (MGH), including signed Transfer Agreement for BBB drug delivery effect study under gravity variations. CEO Hargsoon Yoon also served as Visiting Professor at Harvard Medical School.
Scale indicators9 records
Recent moves12 records
Expansion highlights6 records
Space Lintech competitors and assessment
Company assessmentDirect peers
- SpacePharma: Israel-based SpacePharma offers end-to-end microgravity research services using miniaturized labs flown on the ISS and suborbital vehicles. Directly competes with Space LiinTech's contract research and protein crystallization offerings, with similar B2B pharma/biotech customer base.
- BioServe Space Technologies: University of Colorado-affiliated BioServe has flown life science and biopharma payloads on the ISS for decades. Competes with Space LiinTech on microgravity biopharma contract research and payload hardware, with similar customer segments in pharma, biotech, and government.
- Rhodium Scientific: Rhodium Scientific provides contract microgravity research services for biotech, pharma, and academic customers, including ISS experiment design and operations. Closely comparable business model and target customer base to Space LiinTech's contract research offering.
- Yuri (formerly yuri.gravity): Germany-based Yuri operates microgravity research services and hardware including centrifuge-based and suborbital platforms. Directly comparable as a microgravity R&D services provider targeting pharma and biotech customers, with overlap in protein crystallization and bioprocessing use cases.
- Space Tango: Space Tango provides ISS-based payload services and microgravity research for biotech, pharma, and technology customers. Directly comparable as a turnkey microgravity R&D services provider with similar hardware-and-service business model.
Broad incumbents
- Voyager Technologies: NYSE-listed Voyager is a commercial space company building Starlab commercial space station and operating ISS services. Functions both as Space LiinTech's named customer/partner and as a broad incumbent in commercial space infrastructure relevant to the same payload ecosystem.
- Redwire Corporation: Redwire is a publicly listed space hardware and biotech company operating ISS payloads including bioprinting and pharma research platforms. Comparable in space-based life sciences and biomanufacturing, with broader space infrastructure portfolio as a larger incumbent.
- Axiom Space: Axiom Space operates commercial ISS missions and is building Axiom Station, a commercial space station. Functions as adjacent infrastructure partner and potential venue for Space LiinTech's biopharma payloads once commercial stations replace ISS.
Emerging players
- LambdaVision: LambdaVision uses microgravity on the ISS to manufacture protein-based retinal implants. Niche emerging player focused on a specific microgravity biomanufacturing use case, overlapping with Space LiinTech's BEE-FRM/FPM orbital manufacturing thesis.
- Angiex: Angiex develops antibody-drug conjugates validated on ISS-based microgravity experiments. Emerging biotech using space-based research as part of therapeutic development pipeline, comparable as a customer-side peer leveraging microgravity biopharma platforms.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Space Lintech social profiles
Digital presenceSpace Lintech financial estimates
Financial estimateRevenue estimate
Valuation estimate
Space Lintech leadership team
Management profileNumber of profiles
Profiles6 records
Space Lintech funding detail
Funding detailFunding overview
Funding rounds1 record
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Space Lintech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Space Lintech
What does Space Lintech do?
Space Lintech provides microgravity-enabled contract research services and biopharma platforms for the pharmaceutical and biotechnology industries. Its core products are the BEE (Biomedical Extraterrestrial Enclosure) platform family—including BEE-PC1, BEE-1000, BEE-1012, and BEE-FRM/FPM—that enable protein crystallization, bioprocess studies, and API manufacturing on the ISS and in LEO satellites. Complementing the space hardware are ground-based drop towers, the Gravito-Electroporation gene delivery platform for cell therapies, and end-to-end payload integration and mission operations services.
Is Space Lintech a public or private company?
Space Lintech is a private company. It is classified as venture growth investor backed and is currently operating.
When was Space Lintech founded?
Space Lintech was founded in 2021. It employs 1 to 10 people.
Where is Space Lintech based?
Space Lintech is headquartered in Daejeon, South Korea, in the Asia region.
How does Space Lintech make money?
Four revenue lines are on record. Contract Research Services - Protein Crystallization is the primary driver. The others are contract Manufacturing - Pharmaceuticals and APIs, technology Development and Validation Services and ISS and Satellite Payload Services.
Who are Space Lintech's main competitors?
Direct peers on record are SpacePharma, BioServe Space Technologies, Rhodium Scientific, Yuri (formerly yuri.gravity) and Space Tango. Broad incumbents are Voyager Technologies, Redwire Corporation and Axiom Space. Emerging players are LambdaVision and Angiex.
Does Space Lintech have an API?
No public API is recorded for Space Lintech.
What industry is Space Lintech in?
Space Lintech's product category is Space-based Biopharmaceutical Research Services. Its primary akta.pro industry code is IMABACAD, Space Payloads & Instruments (Sensors, Comms, EO/IR), with a secondary code of HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays). Its NAICS code is 334511 and its SIC code is 3760.